scispace - formally typeset
M

Michael J. Mack

Researcher at Scott & White Hospital

Publications -  634
Citations -  36680

Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.

Papers
More filters
Journal ArticleDOI

Leaflet immobility and thrombosis in transcatheter aortic valve replacement.

TL;DR: The incidence and diagnostic criteria for THV thrombosis are summarized, the pathophysiological mechanisms that may lead to thrombus formation, its natural history, potential clinical implications and treatment for patients are discussed.
Journal ArticleDOI

Description of a Method to Obtain Complete One-Year Follow-Up in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

TL;DR: Using a comprehensive approach, a multidisciplinary process involving clinical personnel, data and quality managers, and research coordinators was able to determine survival status in 100% of patients who underwent TAVI.
Journal ArticleDOI

The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.

TL;DR: In this paper , the authors compared 1-year outcomes between transcatheter aortic valve replacement (TAVR) patients with bicuspid aortric valve (BAV) morphology and clinically similar patients having tricusid aureic valve (TAV) morphologies.
Journal ArticleDOI

Pathology of balloon-expandable transcatheter aortic valves

TL;DR: The Placement of AoRtic TraNscathetER Valves trials (PARTNER) showed favorable safety and efficacy versus medical or surgical therapy in inoperable, high, and intermediate surgical risk patients with severe aortic stenosis.
Journal ArticleDOI

Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation

TL;DR: This study was to determine if the level of sCD30 prior to heart transplant (HTx) could categorize the patients into high or low immunologic risk for post‐Tx outcome.